|
Volumn 24, Issue 3, 2001, Pages 247-250
|
Super high-dose intraarterial cisplatin infusion under percutaneous pelvic perfusion with extracorporeal chemofiltration for advanced uterine cervical carcinoma: II. Its impact on clinical response and subsequent surgery
a a a a a a a a |
Author keywords
Extracorporeal chemofiltration; Intraarterial chemotherapy; Neoadjuvant chemotherapy; Percutaneous pelvic perfusion; Uterine cervical carcinoma
|
Indexed keywords
CISPLATIN;
ADULT;
ADVERSE DRUG REACTION;
AGED;
ARTICLE;
CANCER MORTALITY;
CANCER STAGING;
CANCER SURGERY;
CANCER SURVIVAL;
CARCINOMA CELL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DRUG ADMINISTRATION ROUTE;
DRUG EFFICACY;
DRUG INFUSION;
DRUG MEGADOSE;
DRUG RESPONSE;
FEMALE;
FOLLOW UP;
HEMOFILTRATION;
HISTOLOGY;
HUMAN;
PELVIS;
PELVIS LYMPH NODE;
PROGNOSIS;
UTERINE ARTERY;
UTERINE CERVIX CARCINOMA;
ADENOCARCINOMA;
ADULT;
AGED;
CARCINOMA, ADENOSQUAMOUS;
CARCINOMA, SQUAMOUS CELL;
CHEMOTHERAPY, CANCER, REGIONAL PERFUSION;
CISPLATIN;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
INFUSIONS, INTRA-ARTERIAL;
MIDDLE AGED;
NEOPLASM STAGING;
PILOT PROJECTS;
UTERINE NEOPLASMS;
|
EID: 0034987707
PISSN: 02773732
EISSN: None
Source Type: Journal
DOI: 10.1097/00000421-200106000-00007 Document Type: Article |
Times cited : (12)
|
References (20)
|